Pfizer buys biotech firm Seagen for $43 billion

US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.

source https://medicalxpress.com/news/2023-03-pfizer-buys-biotech-firm-seagen.html